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A B S T R A C T
Background: Gait is thought to have a cognitive component, but the current evidence in healthy elderly is mixed.
We studied the association between multiple gait and cognitive measures in a cohort of older people.
Methods: One hundred and seventy-eight cognitively healthy participants from the Whitehall II Imaging Sub-
study had a detailed clinical and neuropsychological assessment, as well as an MRI scan. Spatiotemporal and
variability gait measures were derived from two 10m walks at self-selected speed. We did a linear regression
analysis, entering potential confounders with backwards elimination of variables with p≥ 0.1. The remaining
variables were then entered into a second regression before doing a stepwise analysis of cognitive measures,
entering variables with p < 0.05 and removing those with p≥ 0.1.
Results: Amongst absolute gait measures, only greater stride length was associated with better performance on
the Trail Making Test A (p=0.023) and the Boston Naming Test (p=0.042). The stride time variability was
associated with performance on the Trail Making Test A (p=0.031). Age was associated with poorer walking
speed (p= 0.014) and stride time (p= 0.011), female sex with shorter stride time (p=0.000) and shorter
double stance (p= 0.005). Length of full-time education was associated with faster walking speed (p= 0.012)
and shorter stride time (p= 0.045), and a history of muscular-skeletal disease with slower walking speed
(p=0.01) and shorter stride length (p= 0.015). Interestingly, volume of white matter hyperintensities (WMH)
on FLAIR MRI images did not contribute independently to any of the gait measures (p > 0.05).
Conclusions: No strong relationship between gait and non-motor cognition was observed in a cognitively
healthy, high functioning sample of elderly. Nevertheless, we found some relationships with spatial, but not
temporal gait which warrant further investigation. WMH made no independent contributionto gait.
1. Introduction
Gait disorders and cognitive impairment are common in people over
the age of 65. However, there is considerable heterogeneity in cognitive
ageing [1], and about 20% of even very old people walk well [2]. This
implies that decline in cognition and mobility is not a necessary con-
sequence of aging. Better understanding of gait and cognitive impair-
ment is important in order to identify the drivers of successful ageing.
A recent review of epidemiological and neuropsychological evi-
dence suggested that gait and cognition are closely related, but our
knowledge of their interrelationship is limited [3]. Risk factors for de-
cline in cognition and mobility may overlap, and possibly share pa-
thological mechanisms including neurodegeneration, inﬂammation,
and vascular damage [3]. There is evidence suggesting that gait mea-
sures are diﬀerentially related to distinct cognitive processes [4–6].
Abnormal gait has been linked to structural and functional brain
changes, although the underlying neural networks are poorly under-
stood, unlike the brain correlates of cognitive measures [6,7]. Studying
the gait –cognition relationship can therefore provide further insights
into shared cognitive and motor networks and identify targets for
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intervention [5,7,8]. Delaying cognitive and motor decline has huge
public health implications as these two geriatric syndromes are asso-
ciated with high healthcare costs and poor outcomes such as falls,
disability and mortality [9–11].
A number of studies investigated the relationship between gait and
cognition in healthy elderly, but their results are mixed [4]. The main
focus has been on associations between executive function and gait,
with limited evidence in other cognitive domains, such as memory,
language, visuospatial ability or processing speed [4]. Although most
population-based studies examined the associations between walking
speed and cognitive function, relatively few focused on other gait
variables [4,12]. Stride time variability, for example, may be a more
sensitive indicator of early gait dysfunction and risk of falls than
walking speed [13].
The purpose of this study was to investigate cognitive-motor inter-
actions by examining the associations between a range of cognitive
domains and a range of gait measures using quantitative gait analysis in
a population-based sample of older people. Demnitz et al. also in-
vestigated the relationship between gait and cognition in this sample of
older adults, but used as an outcome gait speed, measured with a
stopwatch, from an earlier phase of the study (phase 9, 2007–2009), as
well as balance and chair stands tests [14].
2. Methods
2.1. Participants
The Whitehall II study, an on-going, prospective cohort study, re-
cruited 10 308 non-industrial civil servants across a range of employ-
ment grades in 1985–1988. They have been followed up at regular
intervals [15]. Of the original 10 308 participants recruited in Phase 1,
6035 participated at the assessment in 2012–13. Eight hundred of these
were randomly selected to take part in the Whitehall II Imaging Sub-
study in 2012–2016. The detailed protocol of the study is described
elsewhere [15]. This paper describes results from 241 participants, who
also underwent gait assessment between November 2013 and January
2015. Participants were included, if they were willing and capable of
giving informed consent, were able to complete cognitive testing and to
walk unaided for 10m. In addition to the general exclusion criteria in
the Whitehall Imaging Sub-study such as contraindications to magnetic
resonance imaging (MRI) scanning or being unable to travel to Oxford
without assistance, participants were excluded from the current ana-
lyses if they had cognitive impairment (deﬁned by MoCA score< 26), a
history of stroke or gross structural brain abnormality (e.g. a brain cyst
or tumour) or missing cognitive and imaging data.
2.2. Procedure
The participants had a detailed clinical interview to conﬁrm psy-
chiatric and medical history, neuropsychological testing using validated
instruments and an MRI scan [15]. The gait analysis was performed
after their clinical and neuroimaging protocol. The Oxford Central
University Research Ethics Committee approved the Whitehall II Ima-
ging Sub-Study and informed written consent was given by all partici-
pants.
2.2.1. Clinical assessment
General information such as age, sex, education, ethnicity, social
class and full-scale IQ (FSIQ) was recorded for all participants, as well
as information on alcohol intake, BMI, blood pressure, physical activity,
depressive symptoms, medical history and current medications, as
previously described [15]. Brieﬂy, FSIQ was estimated from the Test of
Premorbid Functioning (TOPF). Alcohol intake was recorded as average
units of alcohol per week. BMI (kg/m2) was calculated, and partici-
pants were divided into three groups: normal weight (BMI 18.5–24.9),
overweight (BMI 25–29.9) and obese (BMI > 30). Blood pressure was
measured twice in a sitting position, after the cognitive protocol. Phy-
sical activity was measured using the Community Healthy Activities
Model Program for Seniors (CHAMPS) questionnaire. Depressive
symptoms were assessed using the Centre for Epidemiological Studies
Depression Scale (CES-D) with a score of ≥16 representing clinically
relevant depressive symptoms. History of neurological or musculoske-
letal disease, according to ICD-10 Category VI or XIII was gathered by
self-report. The number of prescribed drugs taken per day was re-
corded. MRI data were acquired at the Oxford Centre for Functional
MRI of the Brain (FMRIB) using a 3-Tesla, Siemens Magnetom Verio
scanner with 32-channel head coil. Details of acquisition sequences and
pre-processing have been described previously [15]. White matter hy-
perintensities (WMH) were automatically segmented on FLAIR images
with a newly developed tool, BIANCA (Brain Intensity Abnormality
Classiﬁcation Algorithm), a fully-automated, supervised method for
WMH detection, based on the k-nearest neighbour algorithm [16].
Brieﬂy, BIANCA classiﬁes the image voxels based on their intensity and
spatial features, where the intensity features were extracted from the
images.
2.2.2. Cognitive assessment
The following cognitive test battery was administered to all parti-
cipants, as described previously [15]:
a) Montreal Cognitive Assessment (MoCA): visuospatial abilities,
short-term memory, executive function, attention, working memory,
language and orientation.
b) Trail Making Test version A and B both assess processing speed;
version B adds a measure of cognitive ﬂexibility, i.e. executive
function.
c) Verbal ﬂuency test: letter and category rely on set shifting and
processing speed
d) Digit span: forwards, backwards and sequence; the total score was
included in the analysis – working memory
e) Digit Symbol substitution Test executive function and speed of
processing
f) Rey-Osterrieth Complex Figure Test (RCF): immediate and delayed
recall; visuo-spatial ability and visuospatial memory, but also at-
tention, planning, and working memory
g) Hopkins Verbal Learning Test-Revised (HVLT-R): total recall;
verbal learning and episodic memory
h) Boston Naming Test - confrontational word retrieval, language,
visuo-perceptual skills
i) CANTAB reaction time: simple and choice reaction time: processing
speed and concentration
2.2.3. Gait assessment
Participants performed two walks over a 10-m walkway free of
obstacles at their self-selected walking pace. They started at a static
position at the zero-point and came to a complete stop at the 10-m line.
An inertial measurement unit (IMU) (MTX, Xsens, Netherlands), was
placed over the projected centre of mass (CoM), located over the fourth
lumbar vertebra [17], measuring at a sample frequency of 100 Hz.
We selected gait variables based on comparability with other po-
pulation-based studies. The following absolute measures were used:
walking speed (m/s, walking distance divided by the time taken to
cover 10m); stride length (m, distance between two successive place-
ments of the same foot as derived via inverted pendulum methodology
[18]; stride time (added left and right step time; step time was deﬁned
as the time interval between trough-to-trough CoM excursions during
one gait cycle); and double stance (%, the percent of the total cycle
during which the two feet are on the ground). We also measured three
variability measures reported as coeﬃcient of variation (CoV), namely
CoV Walking speed, CoV Stride length and CoV Stride time.
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2.3. Analysis
2.3.1. Gait analysis
The IMU data were analysed using a custom program written in
LabVIEW2015 (National Instruments, Ireland), to obtain vertical CoM
excursion using IMU translatory acceleration in combination with
previously published methods using quaternion rotation matrices and
double integration [18]. Temporal parameters of gait, were derived
from negative peak-to-peak CoM excursion and expressed in milli-
seconds [18]. Validated and well-established gait models were used to
derive spatial gait parameters, reliant on leg length [19] and foot size
[20–22] in relation to the vertical CoM excursion, resulting in derived
stride length deﬁned as the distance travelled from ipsilateral heel-
strike-to-heelstrike. Relative variability of spatial parameters is deﬁned
as the coeﬃcient of variation (CoV), deﬁned as the ratio of the standard
deviation to the average of stride time and length. Validation studies
have been conducted on this approach in health [23,24] and clinical
conditions [25–27] with and without gait abnormalities. An average of
13 steps, equalling 6 strides per 10m-walk were recorded.
2.3.2. Statistical analysis
Data were analysed using IBM SPSS version 24 for Windows. After
inspection of data for normality, log-transform of the coeﬃcient of
variation measures (because of large positive skew), we did a linear
regression analysis, entering potential confounders (age, sex, leg length,
height, BMI, CES-D depression scores, FSIQ estimate from the Test of
Premorbid Function (TOPF), a history of neurological or musculoske-
letal disease, and volume of WMH as percentage of intracranial volume
[28], eliminating variables successively with regression coeﬃcients
with p≥ 0.1. The remaining variables were then entered into a second
regression before doing a stepwise analysis of cognitive measures
(MoCA, categorical ﬂuency, letter ﬂuency, Trail Making Test A and B,
RCF immediate and delayed recall, HVLT immediate recall, Boston
Naming Test, Digit recall sequence, and Digit symbol substitution test),
entering variables successively with p < 0.05 and removing those with
p≥ 0.1. As these were exploratory analyses (n=7; walking speed,
stride length, stride time, double stance and log-transformed coeﬃ-
cients of variance of walking speed, stride length, and stride time as
dependent variables), p-values< 0.05 were considered to indicate
statistical signiﬁcance.
3. Results
We examined the association between cognitive domains and gait
parameters in a population-based sample of 241 older adults. After
excluding participants with cognitive impairment (deﬁned by MoCA
score< 26; n=48), stroke (n=2), gross structural brain abnormality
on MRI scan (n=7) and missing data (n= 6), the study sample con-
sisted of 178 older people (mean age 69, SD 5.1). Their demographic
and clinical characteristics are summarised in Table 1. The sample was
predominantly male (75%), white (98%), middle class (76%), physi-
cally active and well educated with a median of 15 years of full-time
education. A summary of the gait and cognitive measures is provided in
Table 2.
Eﬀects of potential confounders and cognitive measures on gait
measures (ﬁnal models) are described in Table 3. The log-transformed
coeﬃcients of variation for walking speed and stride length were not
associated with any of the confounders, nor any of the cognitive per-
formance variables. Only the log-transformed coeﬃcient of variation
for stride time was associated with performance in the Trail Making
Test A, in that greater variability of stride time was associated with
longer time needed to complete the trails test. Amongst measures of
gait, only stride length was associated with neuropsychology perfor-
mance, in that greater stride length was associated with better perfor-
mance in the Trail Making Test A and the Boston Naming Test. Of the
confounders, age was associated with poorer walking speed and stride
time, female sex with shorter stride time and shorter double stance.
Length of full-time education was associated with faster walking speed
and shorter stride time, and a history of muscular-skeletal disease with
slower walking speed and shorter stride length. Interestingly, volume of
WMH on FLAIR MRI images did not contribute independently to any of
the gait measures.
Table 1
Demographic and clinical characteristics of the sample.
Variable Summary
N 178
Age (y), mean (SD) 69 (5.1)
Male, n (%) 134 (75)
Ethnicity white, n (%) 175 (98)
Social class, n (%)
Higher
Middle
Lower
29 (17)
130 (76)
12 (7)
Years of full-time education (y), median (IQR) 15 (5)
FSIQ (estimated from TOPF), mean (SD) 116.4 (6.9)
Height (m), mean (SD) 1.73 (0.1)
Weight (kg), mean (SD) 78.1 (13.8)
Leg length(cm), mean (SD) 95.1 (5.8)
BMI, median (IQR) (4)
BMI, n (%)
Normal (BMI 18.5-24.9)
Overweight (BMI 25-29.9)
Obese (BMI > 30)
84 (47)
67 (38)
27 (15)
Alcohol (units/week), median (IQR) 12 (14)
Systolic BP (mmHg), mean (SD) 140.5 (16.3)
Diastolic BP (mmHg), mean (SD) 75.4 (10.4)
CESD total score, median IQR 3 (5)
CESD cases cut oﬀ 15/16, n (%) 11 (5.9)
Number of current medication, median (IQR) 2 (3)
Weekly frequency of moderate exercise, median (IQR) 4 (7)
Weekly calorie expenditure in moderate exercise, median (IQR) 1262 (2094)
ICD-10 (VI) Nervous system disease, n (%) 17 (9.6)
ICD-10 (XIII) Musculoskeletal system and connective tissue
disease, n (%)
66 (37)
Table 2
Summary of outcome measures.
Gait measure
Walking speed (m/s), mean (SD) 1.5 (0.23)
Stride length (m), mean (SD) 1.56 (0.16)
Stride time (ms), mean (SD) 1080 (85)
Walking speed variability (m/s), mean (SD) 0.15 (0.16)
Stride length variability (cm), mean (SD) 0.10 (0.07)
Stride time variability (ms), mean (SD) 0.05 (0.05)
Double Stance (%),mean (SD) 27.6 (8.6)
Neuropsychological test
MoCA total score, median (IQR) 28.5 (2)
Trail Making Test A (sec),a mean (SD) 28.3 (8.4)
Trail Making Test B (sec),a mean (SD) 63 (30)
Rey Complex Figure Immediate Recall, median (IQR) 18 (8)
Rey Complex Figure Delayed Recall, median (IQR) 17(8)
Category ﬂuency, median (IQR) 23 (7)
Letter ﬂuency, median (IQR) 16 (5)
Hopkins Verbal Learning Test total recall, median (IQR) 30 (5)
Boston Naming Test, median (IQR) 59 (2)
Digit span total, median (IQR) 31(8)
Digit Symbol Substitution Test, median (IQR) 64 (14)
CANTAB simple reaction time (ms),a mean (SD) 303.2 (58)
CANTAB 5 choice reaction time (ms),a mean (SD) 336.4 (48)
a Lower scores indicate better performance.
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4. Discussion
4.1. Gait measures
Greater stride length was associated with faster processing speed
and better performance on the Boston Naming Test. Few studies have
investigated the association between processing speed and spatial gait
parameters [8,29], but the results are inconsistent. They used diﬀerent
measures, limiting comparability. Interestingly, other studies also found
associations between spatial parameters (e.g. step length) and cognitive
measures such as executive function, rather than step time [8,29,30].
One hypothesis is that spatial measures relate to cortical areas, parti-
cularly the prefrontal cortex, while step time relies more on the
brainstem and spinal cord [8]. With ageing the peripheral reﬂexes be-
come less sensitive and there is less peripheral drive of gait with more
reliance on central regulation [31]. Song and Geyer suggest feedback
integration to be functionally more important than central pattern
generation in human locomotion [32]. The reﬂexes drive the actions of
calf muscles, which in turn drive gait and steps/strides. Thus, it is
possible that early in ageing, the timing stays similar but spatial mea-
sures are aﬀected.
We did not ﬁnd any association between walking speed and cog-
nitive measures. In contrast to our results, a previous larger study in-
cluding this sample of older adults found that walking speed was as-
sociated with processing speed, category ﬂuency and memory [14]. The
discrepancy could be due to methodological diﬀerences: the two studies
used diﬀerent gait protocols, measured mobility at diﬀerent time-points
(i.e. years before the cognitive assessment vs. at the time of assessment)
and had diﬀerent exclusion criteria (e.g. we excluded participants with
a MoCA<26). Importantly, due to smaller sample size, the current
study may have lacked power to detect small diﬀerences.
Only three studies investigated the relationship between gait and
language; they found association between walking speed and language,
but did not speciﬁcally examine stride length [5,6,33]. The perfor-
mance on the Boston Naming Test, is considerably aﬀected by in-
dividual’s education, IQ and vocabulary [34,35]. This may have con-
founded the results, particularly considering that none of the other
cognitive measures was associated with gait.
In summary, using absolute gait measures we see some relationships
in the spatial, but not the temporal domain, and they may be the initial
marker of change linked with cortical mechanisms.
4.2. Gait variability measures
Previous studies suggest that gait variability measures are foremost
associated with executive function [6,8,36–38]. In this study, lower
stride time variability was associated with processing speed (i.e. shorter
time needed to complete the Trails A test), but against expectation there
was no association between executive function and any gait variability
measure.
4.3. General cognition
None of the gait parameters was signiﬁcantly associated with general
cognition (p > 0.05). In healthy older adults, a meta-analysis provided
evidence of a small positive association between gait and global cog-
nition (12 studies, d= 0.12, 95% CI=0.09 to 0.15, p< .001) [12]. In
this meta-analysis, speed of gait and MMSE were most commonly used.
MMSE has lower sensitivity compared to MoCA [39], i.e. participants
with wider range of cognitive abilities were included in the meta-ana-
lysis. In our study the cognitive scores showed very little variance
(MoCA mean 28.3, SD 1.2), suggesting that a large sample would be
required to detect diﬀerences and ceiling eﬀects might have aﬀected
the results.
Overall, there is evidence to suggest that gait and cognition are
related [3,4,12]. In a cognitively healthy and high-functioning sample
of elderly, however, no strong relationship between gait and non-motor
cognition was observed. As already mentioned, during ageing the per-
ipheral sensory motor reﬂex loses sensitivity; this is associated with
changes in connectivity resulting in enhanced brain activity during
motor tasks [31,40]. When the coupling in the premotor-motor and
peripheral sensory motor system is decreased, the prefrontal cortex
compensates [40]. Michely et al. suggest that ageing results in U-shape
change in premotor-motor connectivity, i.e. early in ageing connectivity
increases, without additional requirement on the prefrontal structures;
with advancing age premotor-motor connectivity starts to decline, in-
creasing the demands on the prefrontal cortex. This model can explain
the robust relationship found in studies with older participants [40].
It is also possible that he stronger relationship reported in studies
with frailer participants was explained by the eﬀect of common un-
derlying brain pathology aﬀecting cognitive and motor networks, ra-
ther than a direct link between gait and cognition. There are plausible
pathophysiological mechanisms to explain this relationship, including
neurodegeneration, inﬂammation and vascular damage; epidemiolo-
gical, but also neuroimaging and intervention studies provide addi-
tional support [3]. Substantial methodological issues, however, limit
the interpretation of the results. They are discussed below, highlighting
the need for a robust methodological approach.
4.4. Methodological considerations and critical evaluation of research
The main strengths of the current study are that it was conducted in
Table 3
Eﬀects of potential confounders and cognitive measures on gait measures (ﬁnal
models).
Model Unstandardized
Coeﬃcients
Standardised
Coeﬃcients
t-value p-value
B Std.
Error
Beta
Walking Speed
(Constant) 0.923 0.361 2.560 0.011
Age −0.008 0.003 −0.174 −2.494 0.014
Leg Length 0.010 0.003 0.247 3.552 0.000
Full-time
Education
0.014 0.006 0.175 2.533 0.012
Musculoskeletal
Disease
−0.061 0.026 −0.168 −2.398 0.01
Stride Length
(Constant) −0.151 0.293 −0.515 0.607
Sex −0.039 0.025 −0.101 −1.566 0.119
Leg Length 0.014 0.002 0.516 8.009 0.000
Musculoskeletal
Disease
−0.035 0.014 −0.144 −2.464 0.015
Trail Making Test
A
−0.003 0.001 −0.135 −2.290 0.023
Boston Naming
Test
0.009 0.004 0.126 2.053 0.042
Stride Time
(Constant) 990.321 94.401 10.491 0.000
Age 3.060 1.191 0.185 2.569 0.011
Sex −54.793 15.295 −0.264 −3.583 0.000
Full-time
Education
−4.236 2.096 −0.147 −2.021 0.045
Musculoskeletal
Disease
16.408 9.516 0.125 1.724 0.086
Duty Factor Double Stance
(Constant) 70.653 20.367 3.469 0.001
Sex −6.274 2.218 −0.297 −2.829 0.005
Height −20.414 10.592 −0.202 −1.927 0.056
Natural Logarithm of Coeﬃcient of Variance Stride Time
(Constant) −3.611 0.169 −21.353 0.000
Trail Making Test
A
0.012 0.006 0.163 2.173 0.031
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a large and well-characterised sample of cognitively healthy older
adults. Also, participants underwent neuroimaging, a comprehensive
neuropsychological testing and quantitative gait assessments providing
temporal, spatial, as well as variability parameters. A sensitive test to
screen for cognitive impairment was used, ensuring the detection of
early cognitive changes. Analyses were controlled for multiple possible
confounders, including not only socio-demographic variables, but also
measures of physical, mental and brain health to exclude or control for
potential pathological changes.
Limitations include the cross-sectional design, preventing us from
making inferences about causality, lack of neurological examination
and relying mainly on self-report to assess physical health. The current
study only focused on a selected number of gait variables, while there
are other aspects of movement not well characterised by our outcome
measures. Also, our sample consisted of relatively younger, mostly
male, high functioning, relatively active and well-educated elderly,
limiting the generalizability of the ﬁndings.
4.5. Gait and health
It is well established that gait is an indicator of health and general
functioning [41,42]. Gait disorders reﬂect age-associated diseases, ra-
ther than simply ageing [42]. They are multifactorial and to reliably
study the relationship between gait and cognition a full physical ex-
amination, including neurological examination is essential. An assess-
ment of disease severity and the detection of subclinical disease can
provide important information as well.
Gait is a multidimensional construct and cannot be characterised by
one parameter. Gait speed is a global marker of gait disturbance related
to central, but also peripheral neuromuscular dysfunction and other
gait measures, such as stride time variability are more speciﬁc corre-
lates of cognitive measures [13,30]. On the other side it is important
that the gait characteristics included in analysis are not redundant.
Using factor analysis, a number of gait models have been proposed
[43–45], but further research is required to conﬁrm their validity. They
diﬀer in the number of suggested domains, e.g. three (pace, rhythm,
variability) [44] versus ﬁve (adding asymmetry and postural control)
[45]. More importantly, gait characteristics do not consistently load
onto identical domains; for example, stride time variability can re-
present the variability [44] or pace [45] domain.
Gait has also been measured using diﬀerent protocols with limiting
comparability. In this study, a self-selected speed and simple gait were
used. Walking at a faster speed or in more challenging environment
imposes higher demands on postural and cognitive control. Previous
studies have found a diﬀerential eﬀect of fast versus self-selected
walking speed on cognition [46,47]. A PET study demonstrated an as-
sociation between increased complexity of gait such as obstacle
avoidance and increased cortical activity [48].
4.6. Cognition and health
Studies classiﬁed as investigating gait and cognition in healthy el-
derly, included participants with cognitive impairment. The MMSE was the
most common screening tool (cut oﬀ<24) [12] and only participants
with dementia were excluded. In some studies, an MMSE cut oﬀ of 18
was used [46], participants who scored 0/1 on the MMSE delayed recall
were included [49], 27% of the sample had impaired MMSE score
(mean, SD 20.97 ± 2.97) (50) or general cognition was not assessed at
all [38].
MMSE has poor sensitivity to detect mild cognitive impairment
(MCI), due to a lack of complexity, dependence on demographic factors
and inadequate assessment of executive and visuospatial function [39].
Ninety-eight percent of people diagnosed with MCI scored ≥24 on
MMSE [39], and executive dysfunction was found to be common
amongst people with a normal MMSE [51]. In contrast, MOCA (cut oﬀ
of< 26) has 90% sensitivity for detecting early cognitive changes [52].
To our knowledge, only four studies have used the MoCA, and they
included participants with MoCA<26 [14,53–55]. Considering that
gait is impaired in MCI compared to normal ageing [44], including
participants with cognitive impairment is likely to aﬀect the results
signiﬁcantly.
Similar to gait, cognition is a multifaceted construct.
Neuropsychological tests overlap in the cognitive domains they mea-
sure. We did not group the tests, as the same tests were classiﬁed as
measuring diﬀerent domains, creating ambiguity. For example, cate-
gory ﬂuency is deﬁned as representing executive function [8,12] or
language [41] and digit span forward as reﬂecting attention/processing
speed [56] or executive function [8,12]. Further, as cognitive domains
are interdependent, it is diﬃcult to assess their individual integrity
without measuring performance in each domain. For instance, impaired
attention will aﬀect performance not only on executive function/at-
tention measures, but also memory. To understand better the in-
dependent contribution of cognitive domains to gait, a comprehensive
battery of neuropsychological tests assessing all domains should be
used.
4.7. Clinical implications
Although there are associations between gait and cognition it is
necessary to address a number of questions before quantitative gait
assessment can become clinically useful. First, we need to specify which
covariates and confounders are relevant, as they need to be matched
between controls and patients. Second, we need to establish not only a
diﬀerence in mean measures, but also compare diﬀerent cut-oﬀs for gait
performance using receiver-operating characteristic (ROC) curves to
optimise sensitivity and speciﬁcity. Finally, we hope future research can
associate particular aspects of gait impairment with speciﬁc causes of
brain diseases or relevant mechanisms. If these conditions are fulﬁlled,
quantitative gait analysis as described could become a useful tool to
complement clinical assessment.
5. Conclusions
No strong relationship between gait and non-motor cognition was
observed in a cognitively healthy, high functioning population-based
sample of elderly. Interestingly, we found some relationships in the
spatial, but not the temporal domain, and they may be the initial
marker of change linked with cortical mechanisms. WMH made no
independent contribution to gait measures in this healthy older sample.
Understanding the relationship between spatial gait and cognition
better, as well as the underlying pathophysiological mechanisms, has
the potential to aid the prevention and treatment of cognitive and gait
disorders [3]. Considering the signiﬁcant public health implications of
delaying cognitive and motor decline, further research is warranted.
Substantial methodological issues hinder the advance in this area of
research, highlighting the need for a robust methodological approach. It
appears that in order to conﬁrm such weak associations in healthy
ageing volunteers, larger samples are required.
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